GO
Loading...
 

Idenix CEO on Hep C Drug Study

Tue 14 Feb 12 | 08:16 AM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Idenix CEO on Hep C Drug Study

Tue 14 Feb 12 | 08:16 AM ET
Insight on the FDA clearing Idenix to resume study of its advanced experimental hepatitis C drug, with Ronald Renaud, Idenix president/CEO.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Go
Displaying results for: Latest Video | US